Immunomodulation as Therapeutic Approach in Schizophrenia and Depression: State of the Art
Authors Diagnosis Course and duration Duration of trial N Study design Concomitant drug COX-2 inhibitor Outcome Zhang et al. (2006) Schizophrenia First manifestation 12 weeks 40 Risperidone (flexible dose) Celecoxib…